Renle Du
Impact in
-
- Cancer-related molecular mechanisms research
-
- Immune cells in cancer
- Immunotherapy and Immune Responses
Papers in
-
- TGF-β signaling in diseases 2
- Oncology 7
- Cancer Cells and Metastasis 4
- Co-authors
- Wenzhi Shen (13 shared papers)Rong Xiang (9 shared papers)Na Luo (7 shared papers)Wenjuan Gao (4 shared papers)Shuangtao Zhao (6 shared papers)Xiaoyuan Zhang (5 shared papers)Wei Zhou (2 shared papers)Na Li (2 shared papers)
- Journals
- British Journal of Cancer (3 papers)Signal Transduction and Targeted Therapy (2 papers)BMC Cancer (2 papers)Cancer Medicine (2 papers)Theranostics (2 papers)
- Partner nations
- ChinaUnited StatesPhilippines
In The Last Decade
Renle Du
22 papers receiving 446 citations
Peers
Comparison fields: 5 of 67
- Cancer Research 86
- Immunology 103
- Oncology 116
- Molecular Biology 204
- Biotechnology 17
Countries citing papers authored by Renle Du
This map shows the geographic impact of Renle Du's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Renle Du with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Renle Du more than expected).
Fields of papers citing papers by Renle Du
This network shows the impact of papers produced by Renle Du. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Renle Du. The network helps show where Renle Du may publish in the future.
Co-authors
The 25 scholars most cited alongside Renle Du, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 69 | |
| 2 | 2019 | 41 | |
| 3 | 2016 | 36 | |
| 4 | 2024 | 34 | |
| 5 | 2018 | 33 | |
| 6 | 2020 | 33 | |
| 7 | 2019 | 32 | |
| 8 | 2020 | 30 | |
| 9 | 2019 | 25 | |
| 10 | 2019 | 19 | |
| 11 | 2018 | 19 | |
| 12 | 2020 | 17 | |
| 13 | 2018 | 17 | |
| 14 | 2019 | 11 | |
| 15 | 2023 | 8 | |
| 16 | 2021 | 8 | |
| 17 | 2023 | 6 | |
| 18 | 2022 | 4 | |
| 19 | 2022 | 4 | |
| 20 | 2023 | 2 |
About Renle Du
Renle Du is a scholar working on Molecular Biology, Oncology, Immunology, Pulmonary and Respiratory Medicine and Biotechnology, having authored 24 papers that have together received 451 indexed citations. Recurring topics across this work include Cancer Cells and Metastasis (4 papers), Cancer Research and Treatments (3 papers), Bone and Dental Protein Studies (2 papers), Cancer Mechanisms and Therapy (2 papers), Hepatocellular Carcinoma Treatment and Prognosis (2 papers), Immunotherapy and Immune Responses (2 papers), TGF-β signaling in diseases (2 papers) and Ferroptosis and cancer prognosis (1 paper). The work is most often cited by research in Cancer Research (86 citations), Immunology (103 citations), Oncology (116 citations), Molecular Biology (204 citations) and Biotechnology (17 citations). Renle Du has collaborated with scholars based in China, United States and Philippines. Frequent co-authors include Wenzhi Shen, Rong Xiang, Na Luo, Wenjuan Gao, Shuangtao Zhao, Xiaoyuan Zhang, Wei Zhou, Na Li, Wancai Yang and Chunze Zhang. Their work appears in journals such as British Journal of Cancer, Signal Transduction and Targeted Therapy, BMC Cancer, Cancer Medicine and Theranostics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.